{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:20:40Z","timestamp":1783952440586,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s10571-014-0152-8","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T01:20:18Z","timestamp":1419816018000},"page":"563-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Candesartan Improves Ischemia-Induced Impairment of the Blood\u2013Brain Barrier In Vitro"],"prefix":"10.1007","volume":"35","author":[{"given":"Gohei","family":"So","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Morofuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Deli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"152_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10571-004-1374-y","volume":"25","author":"NJ Abbott","year":"2005","unstructured":"Abbott NJ (2005) Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25:5\u201323","journal-title":"Cell Mol Neurobiol"},{"key":"152_CR2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10571-012-9862-y","volume":"32","author":"J Benicky","year":"2012","unstructured":"Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM (2012) Six commercially available angiotensin II AT1 receptor antibodies are non-specific. Cell Mol Neurobiol 32:1353\u20131365","journal-title":"Cell Mol Neurobiol"},{"key":"152_CR3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.mvr.2008.06.003","volume":"76","author":"NV Bogatcheva","year":"2008","unstructured":"Bogatcheva NV, Verin AD (2008) The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 76:202\u2013207","journal-title":"Microvasc Res"},{"key":"152_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tips.2005.12.007","volume":"27","author":"RA Bond","year":"2006","unstructured":"Bond RA, Ijzerman AP (2006) Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci 27:92\u201396","journal-title":"Trends Pharmacol Sci"},{"key":"152_CR5","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","volume":"345","author":"JN Cohn","year":"2001","unstructured":"Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators (2001) A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345:1667\u20131675","journal-title":"N Engl J Med"},{"key":"152_CR6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahl\u00f6f","year":"2002","unstructured":"Dahl\u00f6f B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, LIFE Study Group (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995\u20131003","journal-title":"Lancet"},{"key":"152_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-004-1377-8","volume":"25","author":"MA Deli","year":"2005","unstructured":"Deli MA, \u00c1brah\u00e1m CS, Kataoka Y, Niwa M (2005) Permeability studies on in vitro blood-brain barrier models: physiology, pathology and pharmacology. Cell Mol Neurobiol 25:59\u2013127","journal-title":"Cell Mol Neurobiol"},{"key":"152_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1749-6632.2012.06691.x","volume":"1268","author":"U Dirnagl","year":"2012","unstructured":"Dirnagl U (2012) Pathobiology of injury after stroke: the neurovascular unit and beyond. Ann N Y Acad Sci 1268:21\u201325","journal-title":"Ann N Y Acad Sci"},{"key":"152_CR9","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/jcbfm.2011.70","volume":"31","author":"LI Edvinsson","year":"2011","unstructured":"Edvinsson LI, Povlsen GK (2011) Vascular plasticity in cerebrovascular disorders. J Cereb Blood Flow Metab 31:1554\u20131571","journal-title":"J Cereb Blood Flow Metab"},{"key":"152_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00441-003-0751-z","volume":"314","author":"B Engelhardt","year":"2003","unstructured":"Engelhardt B (2003) Development of the blood\u2013brain barrier. Cell Tissue Res 314:119\u2013129","journal-title":"Cell Tissue Res"},{"key":"152_CR11","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/HJH.0b013e32830dd5ee","volume":"26","author":"S Faure","year":"2008","unstructured":"Faure S, Bureau A, Oudart N, Javellaud J, Fournier A, Achard JM (2008) Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors. J Hypertens 26:2008\u20132015","journal-title":"J Hypertens"},{"key":"152_CR12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","volume":"29","author":"MA Fleegal-DeMotta","year":"2008","unstructured":"Fleegal-DeMotta MA, Doghu S, Banks WA (2008) Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab 29:640\u2013647","journal-title":"J Cereb Blood Flow Metab"},{"key":"152_CR13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.freeradbiomed.2011.06.003","volume":"51","author":"PA Fraser","year":"2011","unstructured":"Fraser PA (2011) The role of free radical generation in increasing cerebrovascular permeability. Free Radic Biol Med 51:967\u2013977","journal-title":"Free Radic Biol Med"},{"key":"152_CR14","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/j.1460-9568.2008.06285.x","volume":"27","author":"J Garthwaite","year":"2008","unstructured":"Garthwaite J (2008) Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27:2783\u20132802","journal-title":"Eur J Neurosci"},{"key":"152_CR15","doi-asserted-by":"crossref","first-page":"e69234","DOI":"10.1371\/journal.pone.0069234","volume":"8","author":"R Hafko","year":"2013","unstructured":"Hafko R, Villapol S, Nostramo R, Symes A, Sabban EL, Inagami T, Saavedra JM (2013) Commercially available angiotensin II At2 receptor antibodies are nonspecific. PLoS ONE 8:e69234","journal-title":"PLoS ONE"},{"key":"152_CR16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10571-008-9294-x","volume":"28","author":"T Hiu","year":"2008","unstructured":"Hiu T, Nakagawa S, Hayashi K, Kitagawa N, Tsutsumi K, Kawakubo J, Honda M, Suyama K, Nagata I, Niwa M (2008) Tissue plasminogen activator enhances the hypoxia\/reoxygenation-induced impairment of the blood-brain barrier in a primary culture of rat brain endothelial cells. Cell Mol Neurobiol 28:1139\u20131146","journal-title":"Cell Mol Neurobiol"},{"key":"152_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10571-012-9896-1","volume":"33","author":"S Horai","year":"2013","unstructured":"Horai S, Nakagawa S, Tanaka K, Morofuji Y, Couraud PO, Deli MA, Ozawa H, Niwa M (2013) Cilostazol strengthens barrier integrity in brain endothelial cells. Cell Mol Neurobiol 33:291\u2013307","journal-title":"Cell Mol Neurobiol"},{"key":"152_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-4827(03)00354-9","volume":"290","author":"T Ishizaki","year":"2003","unstructured":"Ishizaki T, Chiba H, Kojima T, Fujibe M, Soma T, Miyajima H, Nagasawa K, Wada I, Sawada N (2003) Cyclic AMP induces phsophorylation of claudin-5 gene in blood-brain barrier endothelial cells via protein-kinase A-dependent and -independent pathway. Exp Cell Res 290:275\u2013288","journal-title":"Exp Cell Res"},{"key":"152_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2010.03.025","volume":"636","author":"H Kataoka","year":"2010","unstructured":"Kataoka H, Murakami R, Numaguchi Y, Okumura K, Murohara T (2010) Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells. Eur J Pharmacol 636:36\u201341","journal-title":"Eur J Pharmacol"},{"key":"152_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156720208783565645","volume":"5","author":"C Kaur","year":"2008","unstructured":"Kaur C, Ling EA (2008) Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 5:71\u201381","journal-title":"Curr Neurovasc Res"},{"key":"152_CR21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4103\/0253-7613.84947","volume":"43","author":"G Khilnani","year":"2011","unstructured":"Khilnani G, Khilnani AK (2011) Inverse agonism and its therapeutic significance. Indian J Pharmacol 43:492\u2013501","journal-title":"Indian J Pharmacol"},{"key":"152_CR22","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/STROKEAHA.108.537225","volume":"40","author":"A Kozak","year":"2009","unstructured":"Kozak A, Ergul A, El-Remessy AB, Johnson MH, Machado LS, Elewa HF, Abdelsaid M, Wiley DC, Fagan SC (2009) Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke 40:1870\u20131876","journal-title":"Stroke"},{"key":"152_CR23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.freeradbiomed.2011.11.002","volume":"52","author":"PR Kvietys","year":"2011","unstructured":"Kvietys PR, Granger DN (2011) Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med 52:556\u2013592","journal-title":"Free Radic Biol Med"},{"key":"152_CR24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","volume":"359","author":"LH Lindholm","year":"2002","unstructured":"Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:1004\u20131010","journal-title":"Lancet"},{"key":"152_CR25","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/01.wnr.0000187636.13147.cd","volume":"16","author":"Q Lu","year":"2005","unstructured":"Lu Q, Zhu YZ, Wong PT (2005) Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats. NeuroReport 16:1963\u20131967","journal-title":"NeuroReport"},{"key":"152_CR26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1124\/mol.64.6.1271","volume":"64","author":"G Milligan","year":"2003","unstructured":"Milligan G (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol 64:1271\u20131276","journal-title":"Mol Pharmacol"},{"key":"152_CR27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10571-007-9195-4","volume":"27","author":"S Nakagawa","year":"2007","unstructured":"Nakagawa S, Deli MA, Nakao S, Honda M, Hayashi K, Nakaoke R, Kataoka Y, Niwa M (2007) Pericytes from brain microvessels strenghthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol 27:687\u2013694","journal-title":"Cell Mol Neurobiol"},{"key":"152_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","volume":"54","author":"S Nakagawa","year":"2009","unstructured":"Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, Kittel A, Tanaka K, Niwa M (2009) A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 54:253\u2013263","journal-title":"Neurochem Int"},{"key":"152_CR29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.107.098475","volume":"51","author":"T Ogihara","year":"2008","unstructured":"Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K, Sato T, Saruta T, Candesartan Antihypertensive Survival Evaluation in Japan Trial Group (2008) Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension 51:393\u2013398","journal-title":"Hypertension"},{"key":"152_CR30","first-page":"232","volume":"18","author":"H Panahpour","year":"2014","unstructured":"Panahpour H, Nekooeian AA, Dehghani GA (2014) Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia\/reperfusion injury in rats. Iran Biomed J 18:232\u2013238","journal-title":"Iran Biomed J"},{"key":"152_CR31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ajh.2010.241","volume":"24","author":"N Pelisch","year":"2011","unstructured":"Pelisch N, Hosomi N, Ueno M, Nakano D, Hitomi H, Mogi M, Shimada K, Kobori H, Horiuchi M, Sakamoto H, Matsumoto M, Kohno M, Nishiyama A (2011) Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats. Am J Hypertens 24:362\u2013368","journal-title":"Am J Hypertens"},{"key":"152_CR32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","volume":"362","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme. Lancet 362:759\u2013766","journal-title":"Lancet"},{"key":"152_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mvr.2008.09.012","volume":"77","author":"N Prasain","year":"2009","unstructured":"Prasain N, Stevens T (2009) The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res 77:53\u201363","journal-title":"Microvasc Res"},{"key":"152_CR34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20120078","volume":"123","author":"JM Saavedra","year":"2012","unstructured":"Saavedra JM (2012) Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders. Clin Sci 123:567\u2013590","journal-title":"Clin Sci"},{"key":"152_CR35","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","volume":"369","author":"RE Schmieder","year":"2007","unstructured":"Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM (2007) Renin-angiotensin system and cardiovascular risk. Lancet 369:1208\u20131219","journal-title":"Lancet"},{"key":"152_CR36","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","volume":"34","author":"J Schrader","year":"2003","unstructured":"Schrader J, L\u00fcders S, Kulschewski A, Berger J, Zidek W, Treib J, Einh\u00e4upl K, Diener HC, Dominiak P, Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group (2003) The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 34:1699\u20131703","journal-title":"Stroke"},{"key":"152_CR37","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.amjhyper.2005.02.013","volume":"18","author":"I Skoog","year":"2005","unstructured":"Skoog I, Lithell H, Hansson L, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group (2005) Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens 18:1052\u20131059","journal-title":"Am J Hypertens"},{"key":"152_CR38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1124\/jpet.113.212613","volume":"349","author":"S Soliman","year":"2014","unstructured":"Soliman S, Ishrat T, Pillai A, Somanath PR, Ergul A, El-Remessy AB, Fagan SC (2014) Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B. J Pharmacol Exp Ther 349:444\u2013457","journal-title":"J Pharmacol Exp Ther"},{"key":"152_CR39","doi-asserted-by":"crossref","first-page":"9032","DOI":"10.1523\/JNEUROSCI.2088-07.2007","volume":"27","author":"K Wosik","year":"2007","unstructured":"Wosik K, Cayrol R, Dodelet-Devillers A, Berthelet F, Bernard M, Moumdjian R, Bouthillier A, Reudelhuber TL, Prat A (2007) Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. J Neurosci 27:9032\u20139042","journal-title":"J Neurosci"},{"key":"152_CR40","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1046\/j.1471-4159.1997.68031234.x","volume":"68","author":"K Yamada","year":"1997","unstructured":"Yamada K, Nabeshima T (1997) Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats. J Neurochem 68:1234\u20131243","journal-title":"J Neurochem"},{"key":"152_CR41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2353\/ajpath.2008.070076","volume":"172","author":"M Yamamoto","year":"2008","unstructured":"Yamamoto M, Ramirez SH, Sato S, Kiyota T, Cerny RL, Kaibuchi K, Persidsky Y, Ikezu T (2008) Phosphorylation of caludin-5 and occluding by Rho kinase in brain endothelial cells. Am J Pathol 172:521\u2013533","journal-title":"Am J Pathol"},{"key":"152_CR42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00210-007-0215-1","volume":"377","author":"N Yasuda","year":"2008","unstructured":"Yasuda N, Akazawa H, Qin Y, Zou Y, Komuro I (2008) A novel mechanism of mechanical stress-induced angiotensin II type 1-receptor activation without the involvement of angiotensin II. Naunyn Schmiedebergs Arch Pharmacol 377:393\u2013399","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"152_CR43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1359-6446(03)02873-3","volume":"8","author":"KA Youdim","year":"2003","unstructured":"Youdim KA, Avdeef A, Abbott NJ (2003) In vitro trans-monolayer permeability calculations: often forgotten assumptions. Drug Discov Today 8:997\u20131003","journal-title":"Drug Discov Today"},{"key":"152_CR44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrd873","volume":"1","author":"MA Zaman","year":"2002","unstructured":"Zaman MA, Oparil S, Calhoun DA (2002) Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov 1:621\u2013636","journal-title":"Nat Rev Drug Discov"},{"key":"152_CR45","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.neuroscience.2010.09.029","volume":"171","author":"M Zhang","year":"2010","unstructured":"Zhang M, Mao Y, Ramirez SH, Tuma RF, Chabrashvili T (2010) Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171:852\u2013858","journal-title":"Neuroscience"},{"key":"152_CR46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","volume":"6","author":"Y Zou","year":"2004","unstructured":"Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, Komuro I (2004) Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 6:499\u2013506","journal-title":"Nat Cell Biol"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-014-0152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-014-0152-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-014-0152-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T14:10:22Z","timestamp":1559225422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-014-0152-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,30]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1007\/s10571-014-0152-8","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,30]]}}}